• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Effect of CAD on Lung Cancer Screening

Article

Radiologists' use of CAD systems as a second reader to catch missed nodules during lung cancer screening.

Computer-aided detection (CAD) systems can be a useful second reader back-up for radiologists screening for lung cancer, according to an article published in Radiology.

Researchers from the Icahn School of Medicine at Mount Sinai in New York City and Cornell University, Ithaca, NY, sought to determine if CAD was a useful tool to help radiologists detect lung cancers during early imaging.

The researchers obtained images of 50 lung cancers that manifested as a solid nodule on CT scans in annual rounds of screening (time 1). Time zero was when all cancers were missed. Four CAD systems (CAD 1, CAD 2, CAD 3, and CAD 4) were compared to the radiologists’ findings. Two radiologists assessed the CAD-system detected nodules, and they also documented the solid nodules that were not detected by the CAD system.

The average diameter of the 50 cancers at time 0 and time 1 was 4.8 mm and 11.4 mm, respectively. The results showed that the CAD systems detected at least 56% of the nodules.

 
Time 0
Time 1
CAD 1
56%
74%
CAD 2
70%
82%
CAD 3
68%
82%
CAD 4
60%
78%

 

 

 

 

 

 

The number of CAD-system–detected nodules that were rejected per CT scan for CAD systems 1 to 4 at time 0 was 7.4, 1.7, 0.6, and 4.5 respectively.

The researchers concluded that most of the lung cancers, up to 70%, that had not been detected by the radiologist upon screening were detected by the CAD systems, however, about 20% of the nodules that were detected by radiologists were not picked up by the CAD system.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.